Test Price
2,800 AED✅ Home Collection Available
FRRS1L Gene Dysautonomia – Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
With a diagnostic accuracy of 99.9% under ISO 9001:2015 accredited processing, this single‑gene NGS test for FRRS1L provides an unequivocal molecular diagnosis for hereditary dysautonomia and associated neurodegenerative risk, performed entirely within the UAE under DHA‑licensed protocols at DNA Labs UAE.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Genetic Counselling and result interpretation provided.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The FRRS1L Gene Dysautonomia Genetic Test precisely identifies pathogenic mutations in the FRRS1L gene, which are directly linked to early‑onset autonomic nervous system dysfunction and neurodegenerative phenotypes. This targeted single‑gene analysis confirms a molecular diagnosis in patients with unexplained autonomic instability, familial dysautonomia symptoms, or a relevant family history, enabling clinicians to implement personalised management strategies.
| Feature | Our FRRS1L NGS Test | Closest Alternative |
|---|---|---|
| Precision | Single‑gene full‑coverage NGS with 99.9% analytical sensitivity | Broad multi‑gene panel; may miss rare regulatory variants |
| Methodology | Next-Generation Sequencing (NGS) – gold standard, LC‑MS/MS not required | Sanger sequencing or limited exome analysis |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (average) |
| Regulatory Compliance | DHA-licensed laboratory (Facility: 1143) at DNA Labs UAE, ISO 9001:2015 certified | May lack local UAE accreditation |
Physician Insight & Safety Protocols
"Understanding the genetic basis of autonomic dysfunction transforms how we approach treatment. As a medical geneticist, I view each FRRS1L variant in the context of your family history and clinical presentation, ensuring that the molecular findings translate into actionable, personalised care."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
⚠️ Do not discontinue or alter prescribed medication without consulting your treating physician. Genetic results inform therapy adjustments exclusively under specialist supervision. Always carry your current medication list to all appointments.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Blood transfusion within the last 4 weeks; inability to attend a mandatory genetic counselling session for informed consent under UAE regulations.
- Emergency Red Flags: Seek immediate emergency care if you experience sudden collapse, severe orthostatic dizziness, fainting (syncope), extreme heart rate fluctuations (tachycardia or bradycardia), or difficulty breathing – regardless of test timing or results.
Patient FAQ & Clinical Guidance
1. What is the FRRS1L gene test used for?
The FRRS1L genetic test detects mutations linked to hereditary dysautonomia and neurodegenerative disorders, guiding precise neurological care. It confirms a molecular diagnosis in patients with unexplained autonomic instability, early‑onset dysautonomia, or a family history of similar symptoms, enabling targeted therapy and family counselling.
2. How is the test performed and what is the sample collection process?
A certified phlebotomist collects a small blood sample (whole blood, extracted DNA, or FTA card blood spot) at your home under temperature‑controlled cold‑chain protocols. Following a mandatory genetic counselling session, the sample is transported to our ISO‑accredited laboratory at DNA Labs UAE for NGS analysis. Results are typically available within 3–4 weeks.
3. What does a positive result mean and what are the next steps?
A positive result indicates a pathogenic mutation in the FRRS1L gene, requiring specialist neurological consultation and potentially family screening. Your consultant medical geneticist will integrate this finding with your complete clinical picture to tailor a management plan, which may include autonomic function testing, lifestyle modifications, and medication adjustments under close supervision.
4. Is genetic counselling required before testing?
Yes, mandatory genetic counselling is required for informed consent prior to sample collection. This session ensures you understand the implications of testing, potential outcomes, and your rights regarding genetic data under UAE law. Our team at DNA Labs UAE will coordinate this counselling appointment.
UAE Regulatory & Data Privacy Adherence
This test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License Number 1143 and is ISO 9001:2015 Certified (INT/EGQ/2509DA/3139). Genetic counselling must precede sample collection and result disclosure.
Clinical & Logistical Metadata
| Test Name | FRRS1L Gene Dysautonomia – Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | G90.1 |
| LOINC Code | 87809-4 |
| DHA Facility License & Laboratory Address | 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians